Joel Greenblatt's XBI Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 4,617 shares of State Street SPDR S&P Biotech ETF (XBI) worth $728,009, representing 0.00% of the portfolio. First purchased in 2026-Q3, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Joel Greenblatt has initiated a new position in XBI, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's State Street SPDR S&P Biotech ETF (XBI) Holding Value Over Time
Track share changes against reported price movement
Quarterly State Street SPDR S&P Biotech ETF (XBI) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +4,617 | New Buy | 4,617 | $157.68 |
Joel Greenblatt's State Street SPDR S&P Biotech ETF Investment FAQs
Joel Greenblatt first purchased State Street SPDR S&P Biotech ETF (XBI) in Q3 2026, acquiring 4,617 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held State Street SPDR S&P Biotech ETF (XBI) for 1 quarters since Q3 2026.
Joel Greenblatt's largest addition to State Street SPDR S&P Biotech ETF (XBI) was in Q3 2026, adding 4,617 shares worth $728,009.
According to the latest 13F filing for Q3 2026, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 4,617 shares of State Street SPDR S&P Biotech ETF (XBI), valued at approximately $728,009.
As of the Q3 2026 filing, State Street SPDR S&P Biotech ETF (XBI) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in State Street SPDR S&P Biotech ETF (XBI) was 4,617 shares, as reported at the end of Q3 2026.